Carductal
20 mg № 30, № 60
Group of action
Active ingredient
Dosage form
Film-coated tablets
ATC code
C01EB15
RX/OTC
RX
Marketing authorisation no.
UA/4030/01/01
General properties
Pharmacotherapeutic group
Cardiological agents. Trimetazidine.
Indications
- To adults trimetazidine is indicated for the symptomatic treatment of stable angina, when there is an insufficient efficacy or intolerance to first-line antianginal drugs.
Contraindications
Hypersensitivity to the active substance or to any excipient Parkinson's disease, parkinsonism symptoms, tremor, a syndrome of "restless legs" and other movement disorders, related to the above. Severe renal impairment (creatinine clearance 30 ml / min).
Pharmaceutical characteristics
Basic physical and chemical properties
Round-shaped coated tablets, from red to dark red color, the upper and lower surfaces are convex. At fault when viewed under a microscope can see a core surrounded by one continuous layer.
Shelf life
3 years.
Storage conditions
Keep at temperature not exceeding 30 °С.
Keep out of reach of children.
RX
Manufacturer
PJSC "Technolog".
Location
8, Stara Prorizna st., Uman 20300 Cherkasy region, Ukraine.
